Biotechnology | NIH | Oncology | Therapeutics
Roswell Park’s Dr. Pawel Kalinski lead $14.5 million NCI-funded immunotherapy effort
On Apr. 16, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
-
-
Landmark study of adolescent brain development renewed for additional seven years
On Apr. 15, 2020, the National Institutes of Health renewed its commitment to the Adolescent Brain Cognitive Development…
-
Biotechnology | Diagnostics | Neurology | NIH
NIH BRAIN Initiative tool helps researchers watch neural activity in 3D
On Apr. 13, 2020, an ultra-fast, 3D imaging technique called SCAPE microscopy, developed through the National Institutes of…
-
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
-
Autoimmunity may be rising in the United States
On Apr. 8, 2020, NIH scientists and collaborators report that autoimmunity, a condition in which the bodyﾒs immune…
-
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
-
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
-
Biotechnology | Genomics | NIH | Rare Disease | Therapeutics
NIH researchers discovered gene for rare disease of excess bone tissue growth
On Mar. 31, 2020, researchers at the National Institutes of Health announced they had discovered a second gene…
-
CIRM approved $5 Million in emergency funding for COVID-19 research
On Mar. 27, 2020, in response to the crisis caused by the COVID-19 virus in California and around…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
-
Biotechnology | COVID-19 | Diagnostics | Medical Device | Medicine | NIH | Non-Profit Research | Therapeutics
National Library of Medicine expanded access to coronavirus literature through PubMed Central
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point of Care molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
Biotechnology | Diagnostics | Medicine | NIH | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
-
Resverlogix clinical candidate apabetalone featured as potential COVID-19 treatment in publication
On Mar. 23, 2020, Resverlogix announced a bioRxiv publication that has shown apabetalone to inhibit specialized proteins –…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
-
NIH shifted non-mission-critical laboratory operations to minimal maintenance phase
On Mar. 20, 2020, to further reduce the risk of transmission of COVID-19 and enhance the safety of…
-
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
-
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
-
NIH Reported First Known Employee with COVID-19 Infection
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, declared a COVID-related emergency under Section 501(b) of the Stafford Act [18]. Under the…
-
Biotechnology | Medicine | NIH | Therapeutics
NIH researchers discovered tooth-enamel protein in eyes with dry AMD
On Mar. 13, 2020, researchers at the National Eye Institute (NEI) reported finding a protein that normally deposits…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
-
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
-
Biotechnology | HIV | NIH | Therapeutics
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
-
Winship Cancer Institute’s multiple myeloma team awarded $5 million grant from the Leukemia & Lymphoma Society
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Innovation Pharma Brilacidin received by US Regional Biocontainment Lab for testing against COVID-19
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
-
Neurology | NIH | Therapeutics
Scientists monitored brains replaying memories in real time
On Mar. 5, 2020, in a study of epilepsy patients, researchers at the National Institutes of Health (NIH)…
-
$100 million investment helped hospitals across Alberta upgrade operating rooms
On Mar. 5, 2020, a $100 million government investment was announced that helped hospitals across the province upgrade…
-
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
